Analyst Research Report Snapshot

Title:

HCL Technologies Ltd. (HCLT) | Q2FY13 Result

Price:

$46.00

Provider:

IndiaNivesh Securities Pvt Ltd

Date:

17 Jan 2013

Pages:

5

Type:

AcrobatPDF

Companies referenced:

HCLT.NS

Available for Immediate Download
Summary:

 Result Update HCL Technologies Ltd. (HCLT) | Q2FY13 Result Update | Above expectation performance; Poor show from software services continues.... | HCL Technologies Ltd (HCLT) Q2FY13 performance was above our expectations on all fronts. USD revenues grew by 3.6% qoq to $1,154mn (INSPL est: $1150mn). The revenue growth was led by Infrastructure (+10.9% qoq), BPO (+1.8% qoq) and Software (+0.9% qoq) services. During the quarter, the company reported volume growth of 3.0% qoq (v/s Infosys +2.7% qoq, TCS +1.23% qoq) at company level. However, volume/pricing growth in IT services was only 0.4%/0.5% during the quarter. The muted performance in IT-services segment during 1HFY13 remains a concern. Rupee revenue grew 3.0% qoq to Rs62.7bn (INSPL est: Rs62.2bn). Despite wage hike (90 bps impact) and increased SG&A spend, EBITDA margin expanded 39.9bps qoq (to 22.6%) due to uptake in employee utilization and shift in contract mix. HCLT reported forex loss (net) of Rs125mn (v/s Rs609 mn in Q1FY13 and Rs760mn in Q2FY12). As a result, net profit grew by 8.6% qoq to Rs9.6bn (also led by higher EBITDA). During the quarter, other income went down 21.6% qoq to Rs.279 mn (v/s Rs.356 mn in Q1FY13 and Rs.87 mn in Q2FY12). Adjusting forex loss and other income, net profit was Rs9.5 bn (v/s Rs9.1 bn in Q1FY13 and Rs6.4 bn in Q2FY12). During the quarter, HCLT won 12 multi-year, multi-million dollar contracts which are large integrated engagements (TCV USD 1 bn). Valuations: At CMP of Rs. 703, the stock is trading at 14.7x FY13E (June YE) and 13.5x FY14E (June YE) EPS estimates, which is at 29%/26% discount relative to TCS valuation. The continued muted performance in software services segment remains a concern going-ahead. Higher dependence on Infrastructure & BPO for future revenue and margin expansion increase risk. Any deceleration in the deal wins/demand-environment from key performing segment could significantly affect the performance. As a result, we maintain our NEUTRAL rating on the stock.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.